Attached files
| file | filename |
|---|---|
| EX-32.2 - EXHIBIT 32.2 - KEMPHARM, INC | ex_168897.htm |
| EX-32.1 - EXHIBIT 32.1 - KEMPHARM, INC | ex_168896.htm |
| EX-31.2 - EXHIBIT 31.2 - KEMPHARM, INC | ex_168895.htm |
| EX-31.1 - EXHIBIT 31.1 - KEMPHARM, INC | ex_168894.htm |
| EX-10.214 - EXHIBIT 10.21.4 - KEMPHARM, INC | ex_174650.htm |
| EX-4.9 - EXHIBIT 4.9 - KEMPHARM, INC | ex_168886.htm |
| 10-K - FORM 10-K - KEMPHARM, INC | kmph20191231_10k.htm |
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
We consent to the incorporation by reference in the Registration Statements (No. 333-234235 and No. 333-213926) on Form S-3 and Registration Statements (No. 333-203703, No. 333-210369, No. 333-216858, No. 333-224062 and No. 333-230041) on Form S-8 of KemPharm, Inc. of our report dated February 28, 2020 relating to the financial statements of KemPharm, Inc., appearing in this Annual Report on Form 10-K of KemPharm, Inc. for the year ended December 31, 2019.
/s/ RSM US LLP
Orlando, Florida
February 28, 2020